Skip to content
CoreReport

Zimbabwe Turns Down ‘Lopsided’ US Healthcare Assistance Agreement Over Information Concerns

Health aid image
The offered US financial assistance was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has turned down a significant American health deal valued at 367 million US dollars (272 million pounds) over five years because of the United States' demand for confidential data.

This rejection became public after a government memo from December was leaked, revealing that President Emmerson Mnangagwa deemed the agreement was "lopsided".

An official spokesperson later clarified that the United States was seeking biological samples for scientific study and commercial purposes while was unwilling to guarantee the benefits from future treatments.

"We will now turn to the difficult and regrettable task of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has urged more talks to find a deal suitable to both sides so the nation's critical HIV treatment initiative can be sustained.

Broader Context

Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a high court suspended a similar deal with the US after legal challenges were filed about the safety of citizens' health data.

After resuming the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.

USAID had administered assistance for the American government, but Trump argued its spending was "wasteful" and his government was seeking government-to-government deals to boost transparency and accountability.

According to statements, 16 African countries have to date signed similar agreements, representing over $18.3bn in committed funds.

Specifics of the Rejected Agreement

The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this cooperation would have delivered immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment through American-funded programmes," Tremont commented.

However, official spokesman Nick Mangwana maintained the arrangement was "unequal".

"The proposal required Zimbabwe to surrender its biological resources and data over an extended period, without any equivalent promise of benefiting from any medical innovations – like new medicines or tests – that might result from that provided information," his statement read.

"Put simply, our country would provide the basic resources for medical research with no assurance that the resulting innovations would be available to our people if a future health crisis emerge."

Sovereignty and Global Health

Mangwana further said that the American exit from the global health body and its pursuit of bilateral deals were upending structures previously set up via the global organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with future pandemics.

"This mechanism is designed to guarantee that when a nation contributes its data, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," he added.

"We are open to ongoing dialogue with our US partners on how future collaboration could be arranged in a manner that honours the independence and interests of each country."

Health Experts Response

Medical experts stated it recognised the government's concerns, but urged that talks need to persist considering much of the nation's Aids initiatives depended on foreign aid.

"In cases where technical issues arise, such as those relating to data governance or agreement terms, these can often be resolved via detailed discussion and mutually agreed protections," it said.

The halted deal highlights the ongoing debate between receiving crucial international aid and protecting national sovereignty in an increasingly data-driven world.

Written by

Shawn Riley

A tech journalist and data analyst with over a decade of experience covering digital transformations and emerging technologies across Europe.

CoreReport

Type to search articles.